ACRO Biomedical Co., Ltd. (TPEX:6748)
84.20
+2.50 (3.06%)
Aug 12, 2025, 1:59 PM CST
Paramount Global Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 191.75 | 544.16 | 281.85 | 32.26 | 45.66 | Upgrade |
Short-Term Investments | 307.2 | 35.07 | 35.01 | 30.71 | 71.12 | Upgrade |
Cash & Short-Term Investments | 498.95 | 579.23 | 316.85 | 62.97 | 116.77 | Upgrade |
Cash Growth | -13.86% | 82.81% | 403.18% | -46.08% | 110.56% | Upgrade |
Accounts Receivable | 7.87 | 4.83 | 10.3 | 6.23 | 4.71 | Upgrade |
Other Receivables | 2.15 | 3.39 | 0.17 | 0.08 | 0.19 | Upgrade |
Receivables | 10.02 | 8.23 | 10.47 | 6.31 | 4.9 | Upgrade |
Inventory | 10.7 | 9.51 | 12.51 | 14.63 | 13.46 | Upgrade |
Prepaid Expenses | 9.71 | 10.85 | 12.57 | 18.27 | 17.26 | Upgrade |
Total Current Assets | 529.38 | 607.81 | 352.4 | 102.17 | 152.39 | Upgrade |
Property, Plant & Equipment | 56.23 | 45.81 | 21.89 | 26.39 | 32.45 | Upgrade |
Long-Term Investments | 46.06 | 47.39 | 13.74 | 13.44 | 11.43 | Upgrade |
Other Intangible Assets | 6.33 | 8.47 | 8.01 | 7.97 | 4.02 | Upgrade |
Other Long-Term Assets | 17.32 | 7.25 | 2.49 | 1.31 | 3.14 | Upgrade |
Total Assets | 655.33 | 716.74 | 398.53 | 151.29 | 203.43 | Upgrade |
Accounts Payable | 0.75 | 0.95 | 1.21 | 0.11 | 2.42 | Upgrade |
Accrued Expenses | 9.85 | 8.09 | - | - | - | Upgrade |
Current Portion of Leases | 5.26 | 5.25 | 3.67 | 3.39 | 3.39 | Upgrade |
Current Unearned Revenue | 2.5 | 0.19 | 0.08 | 0.31 | 3.17 | Upgrade |
Other Current Liabilities | 0.1 | 0.33 | 7.72 | 7.53 | 4.9 | Upgrade |
Total Current Liabilities | 18.46 | 14.81 | 12.68 | 11.34 | 13.88 | Upgrade |
Long-Term Leases | 10.59 | 15.85 | 7.25 | 9.93 | 11.14 | Upgrade |
Total Liabilities | 29.05 | 30.66 | 19.92 | 21.27 | 25.02 | Upgrade |
Common Stock | 612.18 | 612.18 | 512.18 | 354.33 | 354.33 | Upgrade |
Additional Paid-In Capital | 251.39 | 250 | 160.3 | 9.56 | 122.66 | Upgrade |
Retained Earnings | -236.71 | -174.62 | -293.5 | -232.62 | -296.34 | Upgrade |
Comprehensive Income & Other | -0.59 | -1.48 | -0.37 | -1.25 | -2.25 | Upgrade |
Shareholders' Equity | 626.28 | 686.08 | 378.61 | 130.02 | 178.41 | Upgrade |
Total Liabilities & Equity | 655.33 | 716.74 | 398.53 | 151.29 | 203.43 | Upgrade |
Total Debt | 15.85 | 21.1 | 10.92 | 13.32 | 14.53 | Upgrade |
Net Cash (Debt) | 483.1 | 558.13 | 305.93 | 49.65 | 102.25 | Upgrade |
Net Cash Growth | -13.44% | 82.43% | 516.20% | -51.44% | 159.22% | Upgrade |
Net Cash Per Share | 7.89 | 10.59 | 6.48 | 1.40 | 3.37 | Upgrade |
Filing Date Shares Outstanding | 61.22 | 54.18 | 47.2 | 35.51 | 30.31 | Upgrade |
Total Common Shares Outstanding | 61.22 | 54.18 | 47.2 | 35.51 | 30.31 | Upgrade |
Working Capital | 510.92 | 593 | 339.72 | 90.83 | 138.52 | Upgrade |
Book Value Per Share | 10.23 | 12.66 | 8.02 | 3.66 | 5.89 | Upgrade |
Tangible Book Value | 619.94 | 677.61 | 370.6 | 122.05 | 174.39 | Upgrade |
Tangible Book Value Per Share | 10.13 | 12.51 | 7.85 | 3.44 | 5.75 | Upgrade |
Machinery | 59.3 | 45.42 | - | - | - | Upgrade |
Construction In Progress | 0.63 | 16.51 | - | - | - | Upgrade |
Leasehold Improvements | 59.04 | 36.36 | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.